Reprint
Pseudorabies Virus, Volume II
Edited by
June 2024
194 pages
- ISBN978-3-7258-1298-1 (Hardback)
- ISBN978-3-7258-1297-4 (PDF)
This book is a reprint of the Special Issue Pseudorabies Virus, Volume II that was published in
Biology & Life Sciences
Medicine & Pharmacology
Public Health & Healthcare
Summary
Pseudorabies virus (PRV) is an important swine pathogen that impacts the swine industry worldwide. PRV belongs to the alphaherpes virus subfamily of the herpesviruses and has been widely used as a model for herpes virus. Most recently, PRV has been reported to sporadically spillover into humans and other animals. This book collates the lastest advances in the field of pseudorabies virus research, including critical reviews and research on viral epidemiology, virus–host interaction, pathogenesis and immunity, and novel antiviral strategies.
Format
- Hardback
License and Copyright
© 2024 by the authors; CC BY-NC-ND license
Keywords
pseudorabies virus; prevention; treatment; drugs; drug targets; Glycyrrhiza polysaccharide; pseudorabies virus; antiviral activity; attachment; internalization; pseudorabies virus; heat shock protein 27; cyclic GMP-AMP synthase; cGAS-STING signaling pathway; ubiquitination; pseudorabies virus; ISG15 knockout mice; in vivo; susceptibility; type I IFN; impair; pseudorabies virus; wildlife; cross-host transmission; vaccination; pseudorabies virus; human; pig; complete genome sequence; comparative genomics; pseudorabies virus; virus modification; virus-vectored vaccines; recombinant PRV; swine infectious disease; pseudorabies virus; latent infection; reactivation; thermoregulation; in vitro model; UL54; PRV variant; variation; vaccine; Bartha-K61; immunity protection; triplex real-time RT-PCR; porcine epidemic diarrhea virus; porcine rotavirus; porcine deltacoronavirus; pseudorabies virus; Enterococcus faecium; immunization; intravenous; pseudorabies virus; classical strain; phylogenetic analysis; recombination; pathogenicity; pseudorabies virus; human infection; antiviral drugs; brincidofovir